C

Co-Diagnostics

D
CODX
USD
-0.04
(-3.2922%)
Market Closed
1,082.00
Volume
-1.23
EPS
-
Div Yield
-0.932540
P/E
37,495,427.35
Market Cap
Today
-2.8926%
1 Week
-2.893%
1 Month
-6.000%
6 Months
-8.915%
12 Months
-5.242%
Year To Date
-11.654%
All Time
0%

Title:
Co/Diagnostics

Sector:
Healthcare
Industry:
Medical Devices
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detectionand/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
Do you need help or have a question?